Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FSLR | MRK |
|---|---|---|
| Price | $172.34 | $144.14 |
| Change today | ▼ 1.61% | ▼ 0.81% |
| Market cap | $18.52B | $355.62B |
| Return, 3 months | -25.7% | +15.0% |
| Return, year to date | -34.0% | +38.9% |
| Return, 1 year | -23.3% | +63.7% |
| P/E (TTM) | 10.6 | 115.3 |
| P/B | 1.8 | 8.5 |
| P/E percentile vs own 5y | 5th | 89th |
| Dividend yield | – | 2.33% |
| Revenue growth (YoY, latest qtr) | -3.7% | +5.1% |
| Net profit growth (YoY) | +23.6% | -130.2% |
| Gross margin | 44.0% | 73.0% |
| Operating margin | 33.6% | 10.5% |
| Net margin | 32.5% | 4.8% |
| Return on equity | 18.5% | 7.0% |
| Analyst target vs. price | +61.3% | +13.2% |
| Analyst buy share | 80% | 83% |
| RSI (14) | 36 | 48 |
| 30-day volatility | 52.4% | 42.4% |
| Max drawdown, 1 year | -45.9% | -11.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
